Russian regulators get GMP training; Report probes U.S. drug distribution;

> Eli Lilly, the Chao Center for Industrial Pharmacy & Contract Manufacturing, and the Parenteral Drug Association have partnered to conduct GMP training for drug regulators in Moscow. Release

> An 80-page URCH Publishing report on U.S. pharmaceutical distribution notes that the 90 to 95 percent of sector revenue garnered by the big three--Cardinal Health, McKesson and AmerisourceBergen--has caught the eye of the Federal Trade Commission for its potential to distort the market. Release

> French biopharmaceutical maker LFB Group has chosen the Apriso FlexNet platform with RFID tracking capabilities for use in its plasma manufacturing operations. Announcement

> Specialty drug maker URL Pharma has acquired an FDA-inspected PharmPro facility in Aurora, IL, for development and manufacturing. Release 

> Generics maker West-ward Pharmaceutical, a U.S. manufacturer of generic prescription products, has opted for SaaS delivery of SmartSolve compliance and quality management products from Pilgrim Software. Announcement

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.